The impact of dilution on intravenous therapy

Journal of Infusion Nursing

Volumn 34, Issue 2, 2011, Pages 117-122

  Larue, Guy D ^a   Martin, Peterson ^b  

^a Precision Vascular Services   (United States)

^b Department of Defense ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD FLOW VELOCITY; BLOOD VOLUME; CARDIOTOXICITY; DILUTION; HUMAN; INTRAVASCULAR TOXICITY; INTRAVENOUS ADMINISTRATION; PHLEBITIS; PREDICTION; PRIORITY JOURNAL;

HEMODILUTION; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; PHLEBITIS; RISK ASSESSMENT;

EID: 79953083432     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/NAN.0b013e31820b7899     Document Type: Article

References (45)

1. Gallo MA. History and scope of toxicology. In: Klaassen CD, ed. Casarett and Doull's Toxicology\The Basic Science of Poisons. 6th ed. New York, NY: McGraw-Hill; 2001:3-10.
2. Eaton DL, Klaassen CD. Principles of toxicology. In: Klaassen CD, ed. Casarett and Doull's Toxicology: The Basic Science of Poisons. 6th ed. New York, NY McGraw-Hill; 2001:11-33.
3. Ramos KS, Melchert RB, Chacon E, Acosta D Jr. Toxic respons-es of the heart and vascular systems. In: Klaassen CD, ed. Casarett and Doull's Toxicology: The Basic Science of Poisons. 6th ed. New York, NY McGraw-Hill; 2001:597-651.
4. Hadaway LC. Anatomy and physiology related to intravenous ther-apy. In: Terry J, ed. Intravenous Therapy: Clinical Principles and Practice. Philadelphia, PA: WB Saunders Company; 1995:81-110.
5. Shelper R. The aging venous system. J Assoc Vasc Access. 2003; 8(3):8-10.
6. Smith JP. Thrombotic complications in intravascular access. J Intraven Nurs. 1998;21(2):96-100.
7. Gregus Z, Klaassen CD. Mechanisms of toxicity. In: Klaassen CD, ed. Casarett and Doull's Toxicology: The Basic Science of Poisons. 6th ed. New York, NY: McGraw-Hill; 2001:35-81.
8. Faustman EM, Omenn GS. Risk assessment. In: Klaassen CD, ed. Casarett and Doull's Toxicology: The Basic Science of Poisons. 6th ed. New York, NY McGraw-Hill; 2001:83-104.
9. Cronin MT. Predicting chemical toxicity and fate in humans and the environment. In: Cronin MT, Livingstone DJ, eds. Predicting Chemical Toxicity and Fate. Washington, DC: CRC Press; 2004:1-13.
10. Terry J, Hedrick C. Parenteral fluids. In: Terry J, ed. Intravenous Therapy: Clinical Principles and Practice. Philadelphia, PA: WB Saunders Company; 1995:151-164.
11. Baldwin DR. Pharmacology. In: Terry J, ed. Intravenous Therapy: Clinical Principles and Practice. Philadelphia, PA: WB Saunders Company; 1995:188-218.
12. Fromm LA, Graham DL. Oxacillin-induced tissue necrosis. Ann Pharmacother. 1999;33(10):1060-1062. (Pubitemid 29489988)
13. Trentesaux AS, Bednarek N, Morville P. Vancomycin and cardiac arrest in the infant. Arch Pediatr. 1998;5(5):521-524. (Pubitemid 28218083)
14. Tuncali B, Karci A, Tuncali BE, et al. Dilution of rocuronium to 0.5 mg/mL with 0.9%. Anesth Analg. 2004;99(3):740-743.
15. Stokes DN, Robson N, Hutton P. Effect of diluting propofol on the incidence of pain on injection and venous sequelae. Br J Anaesth. 1989;62(2):202-203. (Pubitemid 19058738)
16. Hoshal VL. Total intravenous nutrition with peripherally inserted sili-cone elastomer central venous catheters. Arch Surg. 1975;110:644-646.
17. Trissel LA. Handbook on Injectable Drugs. Bethesda, MD: American Society of Health-System Pharmacists;1996:1072.
18. Hadaway L, Chamallas SN. Vancomycin-new perspectives on an old drug. J Infus Nurs. 2003;26(5):278-284.
19. Lanbeck P, Odenholt I, Paulsen O. Dicloxacillin: a higher risk for infusion phlebitis than cloxacillin. Scand J Infect Dis. 2003; 35(6/7):397-400. (Pubitemid 37038634)
20. Shelper RL. Vein anatomy: the inside story. AVA 19th Annual Conference, Savannah, GA: AVA; 2006:53-55
21. Fewtrell L, Bartram J, eds. Water Quality: Guideline, Standards and Health. London, England: IWA Publishing; 2001:280-282.
22. Vancomycin HCl [package insert]. Lake Forest, IL: Hospira Inc; 2009.
23. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs. 2006;29(1S):S37, S49, S53.
24. Perucca R. Changing and discontinuing intravenous therapy. In: Terry J, ed. Intravenous Therapy: Clinical Principles and Practice. Philadelphia, PA: WB Saunders Company; 1995:400-405.
25. Wheeler C, Frey AM. Intravenous therapy in children. In: Terry J, ed. Intravenous Therapy: Clinical Principles and Practice. Philadelphia, PA: WB Saunders Company; 1995:467-494.
26. Perdue M. Intravenous complications. In: Terry J, ed. Intravenous Therapy: Clinical Principles and Practice. Philadelphia, PA: WB Saunders Company; 1995:419-446.
27. Chee S, Tan W. Reducing infusion phlebitis in Singapore hospitals using extended life end-line filters. J Infus Nurs. 2002;25(2):95-104.
28. McKee JM, Shell JA, Warren TA, Campbell P. Complications of intravenous therapy: a randomized prospective study\Vialon vs. Teflon. J Intraven Nurs. 1989;12(5):288-295. (Pubitemid 19237698)
29. Scalley RD, Van CS, Cochran RS. The impact of an IV team on the occurrence of intravenous-related phlebitis. J Intraven Nurs. 1992;15(2):100-109.
30. Lanbeck P, Odenholt I, Paulsen O. Perception of risk factors for infu-sion phlebitis among Swedish nurses. J Infus Nurs. 2004;27(1):25-30. (Pubitemid 38112651)
31. Gallant P, Schultz A. Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters. J Infus Nurs. 2006;29(6):338-345. (Pubitemid 44813693)
32. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med. 1991;114(10):845-854.
33. Weinstein SM. Factor V Leiden impact on infusion nursing prac-tice. J Infus Nurs. 2009;32(4):219-223.
34. Brown-Smith JK, Stoner MH, Barley ZA. Tunneled catheter thrombosis: factors related to incidence. Oncol Nurs Forum. 1990;17(4):543-549.
35. Kearns PJ, Coleman S, Wehner JH. Complications of long arm-catheters: a randomized trial of central vs peripheral tip location. J Parenter Enteral Nutr. 1996;20(1):20-24. (Pubitemid 26032932)
36. Catney MR, Hillis S, Wakefield B, et al. Relationship between peripheral intravenous catheter dwell time and the development of phlebitis and infiltration. J Infus Nurs. 2001;24(5):332-341.
37. White SA. Peripheral intravenous therapy-related phlebitis rates in an adult population. J Intraven Nurs. 2001;24(1):19-24. (Pubitemid 32095207)
38. Lundgren A, Wahren LK, Ek AC Peripheral intravenous lines: time in situ related to complications. J Intraven Nurs. 1996; 19(5):229-238.
39. Palefski SS, Stoddard GJ. The infusion nurse and patient compli-cation rates of peripheral-short catheters. J Intraven Nurs. 2001; 24(2):113-123. (Pubitemid 32230270)
40. Powell J, Tarnow KG, Perucca R. The relationship between peripheral intravenous catheter indwell time and the incidence of phlebitis. J Infus Nurs. 2008;31(1):39-45.
41. James L, Bledsoe L, Hadaway LC. A retrospective look at tip location and complications of peripherally inserted central catheter lines. J Intraven Nurs. 1993;16(2):104-109. (Pubitemid 23146607)
42. Gallant P, Schultz AA. Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters. J Infus Nurs. 2006;29(6):338-345. (Pubitemid 44813693)
43. Lanbeck P, Odenholt I, Paulsen O. Antibiotics differ in their ten-dency to cause infusion phlebitis: a prospective observational study. Scand J Infect Dis. 2002;34(7):512-519.
44. Vesely TM, Stranz M, Masoorli S, Hadaway LC. The diverse and conflicting standards and practices in infusion therapy. J Vasc Access Devices. 2002;7(3):9-25.
45. Forauer AR. Pericardial tamponade in patients with central venous catheters. J Infus Nurs. 2007;30(3):161-167. (Pubitemid 46788204)